Indikationen und Ergebnisse der second-look-Operation bei chemotherapierten Patienten mit metastasiertem Magenkarzinom

[1]  D. Hossfeld,et al.  [The results of a modified FAMeth chemotherapy protocol in metastatic stomach carcinoma]. , 2008, Deutsche medizinische Wochenschrift.

[2]  H. Wilke,et al.  Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Siewert,et al.  Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Macdonald Js,et al.  Chemotherapy of advanced gastric cancer: present status, future prospects. , 1988 .

[5]  O. Dalesio,et al.  An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Bader,et al.  Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer. , 1986, Cancer treatment reports.

[7]  H. O. Klein.  Preoperative chemotherapy in patients with gastric cancer. , 1985, Progress in clinical and biological research.

[8]  C. Gisselbrecht,et al.  5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. , 1980, Annals of internal medicine.

[9]  M. Miyazaki,et al.  A study of survival in patients with stomach cancer treated by a combination of preoperative intra‐arterial infusion therapy and surgery , 1976, Cancer.